Eran Nadav - Net Worth and Insider Trading

Over the past 18 months, Eran Nadav made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 8,387 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .

In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 205,106 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,106 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Eran Nadav made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .

In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Eran Nadav made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .

In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Eran Nadav made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .

In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.

Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.